Advice
Following an abbreviated submission
Ibuprofen intravenous injection 5mg/ml (Pedea) is accepted for use within NHSScotland for the treatment of haemodynamically significant patent ductus arteriosus in pre-term newborn infants of less than 34 weeks gestational age. Safety and efficacy compared to existing alternative treatments has not been formally assessed.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- Ibuprofen intravenous injection 5mg/ml (Pedea®)
- SMC ID:
- 233/06
- Indication:
- Haemodynamically significant patent ductus arteriosus in pre-term newborn infants of less than 34 weeks gestational age
- Pharmaceutical company
- Orphan Europe (UK) Ltd
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 13 February 2006